Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avishay Grupper

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
The American Journal of Cardiology|December 13, 2016
Effect of Pretransplant Continuous-Flow Left Ventricular Assist Devices on Cellular and Antibody-Mediated Rejection and Subsequent Allograft OutcomesEmilija M Nestorovic, Avishay Grupper, Lyle D Joyce, et al.
The American Journal of Cardiology|June 21, 2014
Relation between stroke volume index to risk of death in patients with low-gradient severe aortic stenosis and preserved left ventricular functionElad Maor, Roy Beigel, Avishay Grupper, et al.
Mayo Clinic Proceedings|July 6, 2016
Current Status of Left Ventricular Assist Device TherapyPavol Sajgalik, Avishay Grupper, Brook S Edwards, et al.
Frontiers in Cardiovascular Medicine|May 13, 2022
Hemodynamic Changes After Left Ventricular Assist Device Implantation Among Heart Failure Patients With and Without Elevated Pulmonary Vascular ResistanceAvishay Grupper, Israel Mazin, Kobi Faierstein, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 11, 2017
Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapyAmmar M Killu, Anna Mazo, Avishay Grupper, et al.
Transplantation Direct|November 1, 2016
Sex Related Differences in the Risk of Antibody-Mediated Rejection and Subsequent Allograft Vasculopathy Post-Heart Transplantation: A Single-Center ExperienceAvishay Grupper, Emilija M Nestorovic, Richard C Daly, et al.
Journal of the American Society of Hypertension : JASH|September 17, 2018
Normal-range albuminuria in healthy subjects increases over time in association with hypertension and metabolic outcomesAyelet Grupper, Doron Schwartz, Shlomo Berliner, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 25, 2024
Comparison between invasive cardiac output and left ventricular assist device flow parameterAmitai Segev, Viana Copeland, Mateusz Sokolski, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 6, 2015
Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal diseaseAvishay Grupper, Soon J Park, Naveen L Pereira, et al.
Journal of the American Heart Association|December 30, 2025
Frailty Modifies the Prognostic Effect of Age Among Older Adults With Acute Coronary SyndromeBoris Fishman, Amitai Segev, Saar Ashri, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
The American Journal of Cardiology|December 13, 2016
Effect of Pretransplant Continuous-Flow Left Ventricular Assist Devices on Cellular and Antibody-Mediated Rejection and Subsequent Allograft OutcomesEmilija M Nestorovic, Avishay Grupper, Lyle D Joyce, et al.
The American Journal of Cardiology|June 21, 2014
Relation between stroke volume index to risk of death in patients with low-gradient severe aortic stenosis and preserved left ventricular functionElad Maor, Roy Beigel, Avishay Grupper, et al.
Mayo Clinic Proceedings|July 6, 2016
Current Status of Left Ventricular Assist Device TherapyPavol Sajgalik, Avishay Grupper, Brook S Edwards, et al.
Frontiers in Cardiovascular Medicine|May 13, 2022
Hemodynamic Changes After Left Ventricular Assist Device Implantation Among Heart Failure Patients With and Without Elevated Pulmonary Vascular ResistanceAvishay Grupper, Israel Mazin, Kobi Faierstein, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 11, 2017
Super-response to cardiac resynchronization therapy reduces appropriate implantable cardioverter defibrillator therapyAmmar M Killu, Anna Mazo, Avishay Grupper, et al.
Transplantation Direct|November 1, 2016
Sex Related Differences in the Risk of Antibody-Mediated Rejection and Subsequent Allograft Vasculopathy Post-Heart Transplantation: A Single-Center ExperienceAvishay Grupper, Emilija M Nestorovic, Richard C Daly, et al.
Journal of the American Society of Hypertension : JASH|September 17, 2018
Normal-range albuminuria in healthy subjects increases over time in association with hypertension and metabolic outcomesAyelet Grupper, Doron Schwartz, Shlomo Berliner, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|October 25, 2024
Comparison between invasive cardiac output and left ventricular assist device flow parameterAmitai Segev, Viana Copeland, Mateusz Sokolski, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|May 6, 2015
Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal diseaseAvishay Grupper, Soon J Park, Naveen L Pereira, et al.
Journal of the American Heart Association|December 30, 2025
Frailty Modifies the Prognostic Effect of Age Among Older Adults With Acute Coronary SyndromeBoris Fishman, Amitai Segev, Saar Ashri, et al.
Pageof 8